ÂÜÀòÂÒÂ×

Patrick Hanley, Ph.D., has extensive work experience in the field of cellular and gene therapy. Patrick is currently the Chief and Director of the Cellular Therapy Program and Associate Professor at Children's National Hospital since May 2021. In addition, they are serving as the Director of GMP for Immunotherapy at Children's National Hospital since June 2013.

Dr. Hanley is also involved with various organizations in the field. Patrick is a Commissioning Editor for Cytotherapy at ISCT, the International Society for Cell & Gene Therapy, since September 2020. Patrick is a Co-Founder and member of the Board of Directors at Mana Therapeutics since June 2017. Moreover, Dr. Hanley is a member of the Board of Directors at the Foundation for the Accreditation of Cellular Therapy since January 2019.

Prior to their current positions, Dr. Hanley worked at Baylor College of Medicine. Patrick served as a Postdoctoral Fellow from March 2011 to July 2013, working on translational research projects in the Good Manufacturing Practice (GMP) facility. These projects focused on generating virus-specific T cells from umbilical cord blood for the treatment of viral infections after stem cell transplantation, as well as expanding allogeneic mesenchymal stromal cells (MSCs) for stroke patients. Before their postdoctoral fellowship, they were a Graduate Student at Baylor College of Medicine from August 2006 to March 2011, conducting research on generating virus-specific T cells for adoptive immunotherapy in patients after stem cell transplantation.

Overall, Patrick Hanley, Ph.D. has a strong background in cellular therapy, with experience in research, clinical translation, leadership, and board membership in the field.

Patrick Hanley, Ph.D. pursued their education in a chronological manner, acquiring their degrees in a specific order. In 1999, they attended Irondequoit High School where they achieved their NYS Regents degree in an unspecified field of study. Following this, from 2002 to 2006, Hanley enrolled at Hartwick College and earned their Bachelor of Arts degree in Biology and Chemistry. Lastly, they attended Baylor College of Medicine from 2006 to 2011, specializing in Immunology and obtaining their Ph.D. degree.